Foghorn Therapeutics (FHTX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov6

Foghorn Therapeutics released FY2025 Q3 earnings on November 5, 2025 (EST), actual revenue USD 8.153 M (forecast USD 6.197 M), actual EPS USD -0.2514 (forecast USD -0.3328)

04:00

Foghorn Therapeutics released FY2025 9 Months Earnings on November 5, 2025 (EST) with actual revenue of USD 21.66 M and EPS of USD -0.8359

04:00

Nov5

Foghorn Therapeutics' FHD-909 Begins Phase 1a Clinical Trials for SMARCA4 Mutant Cancers

16:24

Oct30

Foghorn Therapeutics Announces Key Development Program Updates

11:52

Aug6

Foghorn Therapeutics released FY2025 Q2 earnings on August 5 (EST), actual revenue USD 7.557 M (forecast USD 7.097 M), actual EPS USD -0.2847 (forecast USD -0.3585)

03:00

Foghorn Therapeutics released FY2025 Semi-Annual earnings on August 5 (EST), actual revenue USD 13.51 M, actual EPS USD -0.5844

03:00